Sickle Cell Disease
Seiten
1992
|
2nd Revised edition
Oxford University Press (Verlag)
978-0-19-262231-0 (ISBN)
Oxford University Press (Verlag)
978-0-19-262231-0 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Sickle cell disease was one of the first diseases to be explained at the molecular level. This new edition contains many current references and incorporates recent thinking on the biology of the disease and the best practice in its management.
Sickle cell disease was one of the first diseases to be explained at the molecular level. Nevertheless, in the years since the first edition of this book was published, further advances have been made. Much has been learnt about the causes of variability in the natural history of the disease and of the reasons why there are such marked variations in the patterns of morbidity and mortality. The role and importance of genetic modifiers such as alpha-thalassaemia and persisting high levels of fetal haemoglobin, and of the beta-globin haplotype, have been recognized and explored. Studies of the disease which compare geographically separated populations have contributed to understanding this variability. These findings have led to more rigorous thinking about the nature of the disease and a clearer appreciation of how to manage it. This book is intended for professionals: physicians - especially haematologists, medical geneticists, paediatricians, nurses in specialist centres, health planners.
Sickle cell disease was one of the first diseases to be explained at the molecular level. Nevertheless, in the years since the first edition of this book was published, further advances have been made. Much has been learnt about the causes of variability in the natural history of the disease and of the reasons why there are such marked variations in the patterns of morbidity and mortality. The role and importance of genetic modifiers such as alpha-thalassaemia and persisting high levels of fetal haemoglobin, and of the beta-globin haplotype, have been recognized and explored. Studies of the disease which compare geographically separated populations have contributed to understanding this variability. These findings have led to more rigorous thinking about the nature of the disease and a clearer appreciation of how to manage it. This book is intended for professionals: physicians - especially haematologists, medical geneticists, paediatricians, nurses in specialist centres, health planners.
| Erscheint lt. Verlag | 1.8.1992 |
|---|---|
| Zusatzinfo | frontispiece, numerous halftones, line drawings, tables, bibliography |
| Verlagsort | Oxford |
| Sprache | englisch |
| Maße | 160 x 230 mm |
| Gewicht | 1010 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
| Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik | |
| ISBN-10 | 0-19-262231-5 / 0192622315 |
| ISBN-13 | 978-0-19-262231-0 / 9780192622310 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Hämatologie und Internistische Onkologie
Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 73,00
